Skip to content

Efficacy of sublingual misoprostol with or without loading vaginal misoprostol pretreatment in second trimester medical termination of pregnancy: A randomized controlled trial

Efficacy of sublingual misoprostol with or without loading vaginal misoprostol pretreatment in second trimester medical termination of pregnancy: A randomized controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20151007001
Enrollment
106
Registered
2015-10-07
Start date
2015-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

termination of pregnancy second trimester medical termination of pregnancy

Interventions

start misoprostol 800 microgram via vaginal suppo then misoprostol 200 microgram via sublingual every 3 hr(Max dose = 5 dose) ,start misoprostol 400 microgram sublingual every 3 hr(Max dose = 5 dose)
Experimental Drug,Active Comparator Drug
sublingual misoprostol with loading vaginal misoprostol ,sublingual misoprostol without loading vaginal misoprostol

Sponsors

Prapokklao Hospital
Lead Sponsor
Prapokklao Hospital
Collaborator

Eligibility

Sex/Gender
Female
Age
12 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Singleton pregnancy GA 14-24 week 2. obstetric condition a. maternal severe medical condition b. fetal anomaly or abnormal chromosome that nonviable c. fetal thalassemia major d. fetal death

Exclusion criteria

Exclusion criteria: 1. allergy to misoprostol 2. previous cesarean section or myomectomy

Design outcomes

Primary

MeasureTime frame
success rate at 24 and 48 hrs time after start misoprostol Chi-square test

Secondary

MeasureTime frame
induction to abortion time,side effect of misoprostol after abortion timing after start misoprostol , questionaire

Countries

thailand

Contacts

Public Contactkiattisak promwangkwa

Prapokklao Hospital

depapepe42121@gmail.com0810204385

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026